Tandem Diabetes Care, Inc. (TNDM) Q3 2023 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q3: 2023-11-01 Earnings Summary

EPS of -$0.38 misses by $0.02
 | Revenue of $185.62M (-9.52% Y/Y) misses by $7.22M

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET

Company Participants

Susan Morrison - EVP & Chief Administrative Officer
John Sheridan - President, CEO & Director
Leigh Vosseller - EVP, CFO & Treasurer
Jordan Pinsker - VP & Medical Director

Conference Call Participants

Steven Lichtman - Oppenheimer
Brooks O’Neil - Lake Street Capital Markets
Matthew Taylor - Jefferies
Matthew Miksic - Barclays Bank
Joshua Jennings - TD Cowen
Andrew Stafford - Piper Sandler & Co.
Dane Reinhardt - Robert W. Baird & Co.

Operator

Thank you for standing by, and welcome to Tandem's Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. I would now like to hand the call over to EVP and Chief Administrative Officer, Susan Morrison. Madam, you may begin.

Susan Morrison

Hello, everyone, and thanks for joining Tandem's 2023 Third Quarter Earnings Call.

As a reminder, today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and financial performance and operating plans and speak only as of today's date.

There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements. A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings.

We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or other factors. Today's discussion will also include references to a number of GAAP and non-GAAP financial measures. Non-GAAP financial measures are provided to give

Recommended For You

About TNDM Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TNDM